Literature DB >> 34446153

mGlu3 Metabotropic Glutamate Receptors-New Hope for Pharmacotherapy of Schizophrenia.

Mariacristina Mazzitelli1, Volker Neugebauer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34446153      PMCID： PMC9359128          DOI： 10.1016/j.biopsych.2021.06.014

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   12.810


× No keyword cloud information.
  10 in total

1.  Subchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus.

Authors:  Toshihiro Nomura; Yoshihiro Oyamada; Herman B Fernandes; Christine L Remmers; Jian Xu; Herbert Y Meltzer; Anis Contractor
Journal:  Neuropharmacology       Date:  2015-04-30       Impact factor: 5.250

2.  Hippocampal metaplasticity is required for the formation of temporal associative memories.

Authors:  Jian Xu; Marcia D Antion; Toshihiro Nomura; Stephen Kraniotis; Yongling Zhu; Anis Contractor
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

3.  AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.

Authors:  Robert E Litman; Mark A Smith; James J Doherty; Alan Cross; Shane Raines; Lev Gertsik; Stephen R Zukin
Journal:  Schizophr Res       Date:  2016-02-26       Impact factor: 4.939

4.  Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites.

Authors:  Y Tamaru; S Nomura; N Mizuno; R Shigemoto
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

Review 5.  Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.

Authors:  Branden J Stansley; P Jeffrey Conn
Journal:  Trends Pharmacol Sci       Date:  2019-02-26       Impact factor: 14.819

6.  Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.

Authors:  Luisa Di Menna; Max E Joffe; Luisa Iacovelli; Rosamaria Orlando; Craig W Lindsley; Jèrome Mairesse; Pierre Gressèns; Milena Cannella; Filippo Caraci; Agata Copani; Valeria Bruno; Giuseppe Battaglia; P Jeffrey Conn; Ferdinando Nicoletti
Journal:  Neuropharmacology       Date:  2017-10-25       Impact factor: 5.250

7.  Activating mGlu3 Metabotropic Glutamate Receptors Rescues Schizophrenia-like Cognitive Deficits Through Metaplastic Adaptations Within the Hippocampus.

Authors:  Shalini Dogra; Branden J Stansley; Zixiu Xiang; Weilun Qian; Rocco G Gogliotti; Ferdinando Nicoletti; Craig W Lindsley; Colleen M Niswender; Max E Joffe; P Jeffrey Conn
Journal:  Biol Psychiatry       Date:  2021-03-06       Impact factor: 12.810

Review 8.  Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

Authors:  James Maksymetz; Sean P Moran; P Jeffrey Conn
Journal:  Mol Brain       Date:  2017-04-26       Impact factor: 4.041

9.  Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk.

Authors:  S M Saini; S G Mancuso; Md S Mostaid; C Liu; C Pantelis; I P Everall; C A Bousman
Journal:  Transl Psychiatry       Date:  2017-08-08       Impact factor: 6.222

Review 10.  Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review.

Authors:  Francesco Matrisciano; Isabella Panaccione; Danis R Grayson; Ferdinando Nicoletti; Alessandro Guidotti
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.